Assembly Biosciences (ASMB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 19,841 | 52,418 | 45,627 | 59,444 | 46,732 |
| Marketable Securities | 110,406 | 39,192 | 101,000 | 156,969 | 227,311 |
| Receivables | 43 | 944 | 336 | 1,230 | 3,374 |
| TOTAL | $133,787 | $96,967 | $154,204 | $224,493 | $282,780 |
| Non-Current Assets | |||||
| PPE Net | 385 | 743 | 1,139 | 1,600 | 1,830 |
| Investments And Advances | 0 | 0 | 27,972 | 0 | 0 |
| Intangibles | 0 | 0 | 0 | 41,638 | 41,638 |
| Other Non-Current Assets | 2,651 | 4,084 | 7,745 | 15,523 | 13,659 |
| TOTAL | $3,036 | $4,827 | $36,856 | $58,761 | $57,127 |
| Total Assets | $136,823 | $101,794 | $191,060 | $283,254 | $339,907 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 461 | 2,493 | 2,659 | 4,598 | 1,731 |
| Accrued Expenses | 6,629 | 10,439 | 10,263 | 16,431 | 13,112 |
| TOTAL | $39,225 | $16,296 | $16,073 | $24,433 | $24,440 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 30,915 | N/A | N/A | N/A | 6,411 |
| Other Non-Current Liabilities | 1,122 | 101 | 3,325 | 6,725 | 9,082 |
| TOTAL | $56,501 | $2,834 | $6,058 | $18,243 | $42,250 |
| Total Liabilities | $95,726 | $19,130 | $22,131 | $42,676 | $66,690 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 5,483 | 4,327 | 4,008 | 3,186 | 2,718 |
| Common Shares | 5 | 4 | 48 | 34 | 32 |
| Retained earnings | -785,748 | -724,520 | -631,428 | -501,573 | -439,421 |
| Other shareholders' equity | -81 | -803 | -419 | -270 | -201 |
| TOTAL | $41,097 | $82,664 | $168,929 | $240,578 | $273,217 |
| Total Liabilities And Equity | $136,823 | $101,794 | $191,060 | $283,254 | $339,907 |